Cresset, and symposia organizing partners Elixir and Optibrium, thank speakers and delegates for contributing to the successful series of Symposia on Streamlining Drug Discovery, which took place in the US last month.

Presentations we have permission to publish are:

• Hit Finding and Optimization Using Blaze and Forge, AbbVie
• Using AI to Improve the Safety of New Drug Candidates, AstraZeneca
• The CFL: Maximizing Fragment-Target Interaction Space by Design with a Minimal Screening Set, BioBlocks
• Electrostatic Complementarity™ as a New Approach to Visualize and Predict Activity, Cresset
• Managing External Chemistry for Effective Support of Drug Projects, Elixir and Praxis
• Imputation of Protein Activity Data Using Deep Learning, Optibrium and Intellegens
• Using WaterSwap to Assess Target Druggability, Retrophin
• Bigfoot, the Loch Ness Monster, and Halogen Bonds: Separating Rumors from Reality in Molecular Design, Takeda
• Medicinal Chemist’s Relationship with Additivity: Are we Taking the Basics for Granted?, UCSF